BCM
Boxer Capital Management Portfolio holdings
AUM
$199M
This Quarter Return
+89.98%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$199M
AUM Growth
-$134M
(-40%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-98.11%
Top 10 Holdings %
Top 10 Hldgs %
91.42%
Holding
36
New
8
Increased
3
Reduced
7
Closed
16
Top Buys
| 1 |
ITOS
iTeos Therapeutics
ITOS
|
$8.23M |
| 2 |
UroGen Pharma
URGN
|
$7.88M |
| 3 |
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
|
$7.32M |
| 4 |
Kymera Therapeutics
KYMR
|
$4.67M |
| 5 |
Replimune Group
REPL
|
$3.86M |
Top Sells
| 1 |
Nuvalent
NUVL
|
$31.9M |
| 2 |
Avidity Biosciences
RNA
|
$25.5M |
| 3 |
AnaptysBio
ANAB
|
$24.2M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$20.1M |
| 5 |
Revolution Medicines
RVMD
|
$19.3M |
Sector Composition
| 1 | Healthcare | 99.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Legend Biotech
LEGN
$6.66B
| – | – |
-200,000
| Closed | -$6.79M |
|
|
27
Nuvalent
NUVL
$5.83B
| – | – |
-450,000
| Closed | -$31.9M |
|
28
Oric Pharmaceuticals
ORIC
$1.06B
| – | – |
-1,732,571
| Closed | -$9.67M |
|
29
Prelude Therapeutics
PRLD
$69.6M
| – | – |
-2,108,014
| Closed | -$1.62M |
|
30
Prothena Corp
PRTA
$460M
| – | – |
-690,000
| Closed | -$8.54M |
|
|
31
Avidity Biosciences
RNA
$6.48B
| – | – |
-865,000
| Closed | -$25.5M |
|
32
Solid Biosciences
SLDB
$428M
| – | – |
-1,240,700
| Closed | -$4.59M |
|
|
33
Xenon Pharmaceuticals
XENE
$3.02B
| – | – |
-600,000
| Closed | -$20.1M |
|
|
BOLD
34
Boundless Bio
BOLD
$25.7M
| – | – |
-250,000
| Closed | -$378K |
|
|
CLYM
35
Climb Bio, Inc. Common Stock
CLYM
$162M
| – | – |
-145,000
| Closed | -$177K |
|
|
CMRX
36
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-1,810,000
| Closed | -$15.4M |
|